Authors: MOYER JA WOOD A ZALESKA MM AY I FINKLESTEIN SP PROTTER AA

Citation: Ja. Moyer et al., BASIC FIBROBLAST-GROWTH-FACTOR - A POTENTIAL THERAPEUTIC AGENT FOR THE TREATMENT OF ACUTE NEURODEGENERATIVE DISORDERS AND VASCULAR INSUFFICIENCY, Expert opinion on therapeutic patents, 8(11), 1998, pp. 1425-1445

Authors: ZALESKA MM MILLER TL BRAMLETT DR HEYBURN JW GRAESSLE T CHILDERS WE ABOUGHARBIA MA MOYER JA

Citation: Mm. Zaleska et al., NEUROPROTECTIVE EFFICACY IN FOCAL ISCHEMIA OF EAA-090 - A NOVEL COMPETITIVE NMDA RECEPTOR ANTAGONIST, Stroke, 29(1), 1998, pp. 168-168

Authors: KINNEY WA ABOUGHARBIA M GARRISON DT SCHMID J KOWAL DM BRAMLETT DR MILLER TL TASSE RP ZALESKA MM MOYER JA

Citation: Wa. Kinney et al., DESIGN AND SYNTHESIS OF AZABICYCLO[5.2.0]NON-1(7)-EN-2-YL)ETHYL]PHOSPHONIC ACID (EAA-090), A POTENT N-METHYL-D-ASPARTATE ANTAGONIST, VIA THE USE OF 3-CYCLOBUTENE-1,2-DIONE AS AN ACHIRAL ALPHA-AMINO-ACID BIOISOSTERE, Journal of medicinal chemistry, 41(2), 1998, pp. 236-246

Authors: SABB AL STEIN RP VOGEL RL TASSE R AMBURN S FAIRMAN DK KOWAL D MALHOTRA D BOAST CA BARTOLOMEO A MORRIS H SAILER T MOYER JA ABOUGHARBIA M HO DM

Citation: Al. Sabb et al., WAY-131256 IS AN ORALLY-ACTIVE, EFFICACIOUS, AND IN-VIVO FUNCTIONALLYSELECTIVE M-1 AGONIST, Drug development research, 40(2), 1997, pp. 185-192

Authors: SPENCE P FRANCO R WOOD A MOYER JA

Citation: P. Spence et al., MECHANISMS OF APOPTOSIS AS DRUG TARGETS IN THE CENTRAL-NERVOUS-SYSTEM, Expert opinion on therapeutic patents, 6(4), 1996, pp. 345-366

Authors: ABOUGHARBIA M MOYER JA NIELSEN ST WEBB M PATEL U

Citation: M. Abougharbia et al., NEW ANTIHISTAMINES - SUBSTITUTED PIPERAZINE AND PIPERIDINE-DERIVATIVES AS NOVEL H-1-ANTAGONISTS, Journal of medicinal chemistry, 38(20), 1995, pp. 4026-4032